"Mary Bird Perkins Cancer Center in Covington provides state-of-the art radiation therapy and diagnostic imaging, along with vital support services to patients and families in the Northshore region. With highly-experienced and compassionate physicians and team members, Mary Bird Perkins is a key provider within St. Tammany Cancer Center, which offers comprehensive, patient-focused cancer services."

During the past decade, Mary Bird Perkins Cancer Center - Covington conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 15 clinical trials were completed, i.e. on average, 53.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 14 clinical trials were completed. i.e. 466.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mary Bird Perkins Cancer Center - Covington" #1 sponsor was "SWOG Cancer Research Network" with 14 trials, followed by "National Cancer Institute (NCI)" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mary Bird Perkins Cancer Center - Covington" #1 collaborator was "National Cancer Institute (NCI)" with 26 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Mary Bird Perkins Cancer Center - Covington" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Breast Carcinoma" (3 trials), "Breast Adenocarcinoma" (2 trials) and "Estrogen Receptor Negative" (2 trials). Many other conditions were trialed in "Mary Bird Perkins Cancer Center - Covington" in a lesser frequency.

Most popular intervention types in "Mary Bird Perkins Cancer Center - Covington" are "Other" (28 trials), "Drug" (24 trials), "Biological" (12 trials), "Procedure" (7 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (18 trials), "Quality-of-Life Assessment" (12 trials), "Questionnaire Administration" (8 trials), "Biospecimen Collection" (6 trials) and "Nivolumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "Mary Bird Perkins Cancer Center - Covington" are 31 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Mary Bird Perkins Cancer Center - Covington". undefined are not yet recruiting, 6 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Mary Bird Perkins Cancer Center - Covington, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mary Bird Perkins Cancer Center - Covington, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".